FDA Issues Third Approvable Letter for Thelin (Sitaxsentan Sodium)
June 15, 2007 19:31 ET
|
Encysive Pharmaceuticals Inc.
HOUSTON, June 15, 2007 (PRIME NEWSWIRE) -- Encysive Pharmaceuticals Inc. (Nasdaq:ENCY) today announced that the Company has received its third approvable letter from the U.S. Food and Drug...
Canadian Health Authority Approves THELIN (Sitaxsentan Sodium) for Pulmonary Arterial Hypertension
May 30, 2007 17:46 ET
|
Encysive Pharmaceuticals Inc.
HOUSTON, May 30, 2007 (PRIME NEWSWIRE) -- Encysive Pharmaceuticals (Nasdaq:ENCY) today announced that Health Canada's Therapeutic Products Directorate has approved THELIN(tm) (sitaxsentan sodium) 100...
Encysive Pharmaceuticals Reports First Quarter 2007 Financial Results
May 07, 2007 07:00 ET
|
Encysive Pharmaceuticals Inc.
HOUSTON, May 7, 2007 (PRIME NEWSWIRE) -- Encysive Pharmaceuticals (Nasdaq:ENCY) today announced financial results for the first quarter ended March 31, 2007.
"In the quarter, we made significant...
Encysive Pharmaceuticals Previews European Union Activities for 2007
May 01, 2007 02:00 ET
|
Encysive Pharmaceuticals Inc.
HOUSTON, May 1, 2007 (PRIME NEWSWIRE) -- Encysive Pharmaceuticals Inc. (Nasdaq:ENCY) and Encysive (UK) Limited, the Company's European operations, today announced plans to participate in three...
Encysive Pharmaceuticals Announces Conference Call to Discuss First Quarter 2007 Results
April 18, 2007 07:00 ET
|
Encysive Pharmaceuticals Inc.
HOUSTON, April 18, 2007 (PRIME NEWSWIRE) -- Encysive Pharmaceuticals Inc. (Nasdaq:ENCY) will hold an investor conference call on Monday, May 7, 2007 at 8:00 a.m. ET to discuss its first quarter 2007...
Encysive Pharmaceuticals Announces Launch of THELIN (Sitaxentan Sodium) in the Netherlands
April 16, 2007 02:00 ET
|
Encysive Pharmaceuticals Inc.
HOUSTON, April 16, 2007 (PRIME NEWSWIRE) -- Encysive Pharmaceuticals (Nasdaq:ENCY) today announced the commercial availability of THELIN(r)(1) (sitaxentan sodium(2)) 100 mg tablets in the Netherlands...
Encysive Pharmaceuticals Announces Launch of Thelin (Sitaxentan Sodium) in Republic of Ireland
April 02, 2007 03:00 ET
|
Encysive Pharmaceuticals Inc.
HOUSTON, April 2, 2007 (PRIME NEWSWIRE) -- Encysive Pharmaceuticals (Nasdaq:ENCY) today announced the commercial availability of THELIN(r)(a)(sitaxentan sodium(b)) 100 mg tablets in the Republic of...
Encysive Pharmaceuticals Announces Patient Enrollment Initiated for TBC3711 Phase II Study
March 21, 2007 08:00 ET
|
Encysive Pharmaceuticals Inc.
HOUSTON, March 21, 2007 (PRIME NEWSWIRE) -- Encysive Pharmaceuticals Inc. (Nasdaq:ENCY) today announced that the first patient has been enrolled into its Phase II dose-ranging study of oral TBC3711,...
Encysive Pharmaceuticals Reports Fourth Quarter and Year End 2006 Financial Results
March 09, 2007 06:45 ET
|
Encysive Pharmaceuticals Inc.
HOUSTON, March 9, 2007 (PRIME NEWSWIRE) -- Encysive Pharmaceuticals (Nasdaq:ENCY) today announced financial results for the fourth quarter and year ended December 31, 2006, and also provided financial...
THELIN (sitaxentan sodium) Receives Australian Marketing Approval
March 07, 2007 05:00 ET
|
Encysive Pharmaceuticals Inc.
HOUSTON, March 7, 2007 (PRIME NEWSWIRE) -- Encysive Pharmaceuticals Inc. (Nasdaq:ENCY) today announced that the Australian Therapeutic Goods Administration (TGA) has granted marketing approval for...